Keyphrases
Lipophilicity
100%
Cystic Fibrosis
100%
Ivacaftor
100%
F508del
100%
VX-770
100%
Destabilizing Effect
100%
Cystic Fibrosis Transmembrane Conductance Regulator
75%
Negative Effects
37%
VX-809
37%
Phenylalanine
12%
Channel Activity
12%
Non-specific Effects
12%
Total Internal Reflection Fluorescence Microscopy
12%
Inhibitory Effect
12%
Transmembrane Domain
12%
Lipid Bilayer
12%
Combination Therapy
12%
Lung Function
12%
Solute Carrier
12%
Negative Impact
12%
Potentiator
12%
Nucleotide-binding Domain
12%
Processing Defects
12%
Lumacaftor
12%
SLC26A9
12%
SLC6A14
12%
Supported Lipid Bilayer
12%
Bilayer Model
12%
SLC26A3
12%
Lipophilic Derivatives
12%
Biochemistry, Genetics and Molecular Biology
Cystic Fibrosis
100%
Lipophilicity
100%
Cystic Fibrosis Transmembrane Conductance Regulator
100%
Ivacaftor
100%
Lipid Bilayer
33%
Binding Domain
16%
Clinical Study
16%
Fluorescence Microscopy
16%
Phenylalanine
16%
Lumacaftor
16%
SLC26A3
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Lipophilicity
100%
Cystic Fibrosis Transmembrane Conductance Regulator
100%
Ivacaftor
100%
Combination Therapy
16%
Clinical Study
16%
Phenylalanine
16%
Fluorescence Microscopy
16%
Solute Carrier Protein
16%
Lumacaftor
16%